The C-Terminal Half of SARS-CoV-2 Nucleocapsid Protein, Industrially Produced in Plants, Is Valid as Antigen in COVID-19 Serological Tests

BACKGROUND: The fight against the current coronavirus disease 2019 (COVID-19) pandemic has created a huge demand of biotechnological, pharmaceutical, research and sanitary materials at unprecedented scales. One of the most urgent demands affects the diagnostic tests. The growing need for rapid and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Laura, Jurado, Silvia, Llorente, Francisco, Romualdo, Alberto, González, Sara, Saconne, Ana, Bronchalo, Isabel, Martínez-Cortes, Mercedes, Pérez-Gómez, Beatriz, Ponz, Fernando, Jiménez-Clavero, Miguel Ángel, Lunello, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Plant Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354202/
https://www.ncbi.nlm.nih.gov/pubmed/34386028
http://dx.doi.org/10.3389/fpls.2021.699665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354202/
https://www.ncbi.nlm.nih.gov/pubmed/34386028
http://dx.doi.org/10.3389/fpls.2021.699665

Ejemplares similares